Skip to main content
SMS Pharmaceuticals Ltd logo

SMS Pharmaceuticals Ltd — Investor Relations & Filings

Ticker · SMSPHARMA ISIN · INE812G01025 LEI · 335800XXEADQCB7GJ514 BSE.NS Manufacturing
Open in API
Filings indexed 749 across all filing types
Latest filing 2019-10-10 Regulatory Filings
Country IN India
Listing BSE.NS SMSPHARMA

About SMS Pharmaceuticals Ltd

https://smspharma.com/

SMS Pharmaceuticals Ltd specializes in the development and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The organization operates multiple manufacturing units and research centers, maintaining compliance with international regulatory standards including USFDA approvals. Its core product portfolio covers therapeutic areas such as anti-ulcerants, anti-migraine agents, anti-hypertensives, and anti-retrovirals. Beyond its proprietary product line, the company provides Contract Research and Manufacturing Services (CRAMS), offering expertise in process development, chemical synthesis, and analytical validation. The company focuses on delivering high-quality chemical solutions through integrated research and development capabilities, supporting global supply chains with a commitment to technical excellence and operational efficiency.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings
2019-10-10 English
Updates
Regulatory Filings
2019-10-01 English
Updates
Regulatory Filings
2019-10-01 English
Trading Window
Regulatory Filings Classification · 100% confidence The document text is extremely short (117 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, no report content, no announcements, or any textual information to classify as a specific report type. Given the lack of content, the document does not fit any specific filing category and defaults to the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2019-09-30 English
Updates
Regulatory Filings
2019-09-30 English
Updates
Major Shareholding Notification Classification · 95% confidence The document is a detailed disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, and related insider trading regulations. It includes specifics about share acquisition by gift, names of parties involved, shareholding percentages before and after acquisition, and compliance with SEBI regulations. The content is regulatory in nature, focusing on shareholding changes and insider trading disclosures rather than financial results, management changes, or meeting materials. It is not a full financial report or earnings release but a formal regulatory filing about share acquisition and insider trading compliance. Therefore, the document fits best under the category of Major Shareholding Notification (MRQ).
2019-09-18 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.